Oral coumarin anticoagulants that antagonize vitamin K to inhibit clotting factor synthesis for managing atrial fibrillation and venous thromboembolism. Prescribed in outpatient cardiology and hematology clinics by physicians. Distributed by wholesalers to pharmacies and healthcare networks for long-term therapeutic regimens.